PCSK9 Forum is made possible thanks to support from AstraZeneca, LIB Therapeutics, Novartis and Sanofi, all of whom have no influence or control over editorial content. More information is available here »

Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

24th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 22nd April 2026 (Educational supporters)

PCSK9 targeting of LDLR to degradation: SNX17, a new player

PCSK9 targeting of LDLR to degradation: SNX17, a new player

Reports from the 24th Virtual Closed Scientific Expert Meeting of the Editorial Board Professor Jay Horton   Supporters of the 24th Closed Scientific Expert Meeting of the Editorial Board Principal Supporters: AstraZeneca has provided a grant towards this independent project and has had no involvement…

read more »
Posted on 1 May 2026 | Posted by Jay Horton | Posted in 24th Closed Scientific Expert Meeting of the Editorial Board
Cardiomyocyte mitochondrial bioenergetics: Role of PCSK9-mediated degradation of TSPO

Cardiomyocyte mitochondrial bioenergetics: Role of PCSK9-mediated degradation of TSPO

Reports from the 24th Virtual Closed Scientific Expert Meeting of the Editorial Board Professor Jan Borén   Supporters of the 24th Closed Scientific Expert Meeting of the Editorial Board Principal Supporters: AstraZeneca has provided a grant towards this independent project and has had no involvement…

read more »
Posted on 1 May 2026 | Posted by Jan Boren | Posted in 24th Closed Scientific Expert Meeting of the Editorial Board

About PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is a not-for-profit organisation established by leading researchers in the fields of atherosclerosis, lipids and cardiovascular disease. Our mission is to raise awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target.

Editorial Policy

Unless otherwise indicated, opinions expressed in the PCSK9 Education and Research Forum are those of the contributors. All patients should discuss their medication with their healthcare professional. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the PCSK9 Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.
Educational Partners and Supporters
AstraZeneca

AstraZeneca has provided a grant towards this independent project and has had no involvement in its creation or organisation.

LIB Therapeutics

Novartis

Sanofi

© Copyright 2026 PCSK9 Forum. All rights reserved